Edward Graviss, PhD, MPH
Associate Professor of Pathology and Genomic Medicine
Houston Methodist Academic Institute
The Graviss lab uses epidemiology, biostatistics, molecular diagnostics, and population-based surveillance to study a variety of infectious agents, including Mycobacterium tuberculosis. Recent studies from the lab evaluated the new Interferon Gamma Release Assays (IGRAs) in the diagnosis of latent tuberculosis infection and the development and evaluation of point-of-care diagnostic assays for tuberculosis disease.